ApoE glycosylation was shown to be considerably different in cerebral spinal fluid (CSF) than in serum (90) and its extent of sialylation in CSF affects ApoE binding to amyloid beta, thus influencing the development of plaque formation and Alzheimer's disease (91) and suggesting that glycosylation of ApoE may be tissue-specific (90). This evidence concerns the gene APOE and Alzheimer disease.